Urinary Tract Disease
11
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Infectious Complications After Cystectomy: A Prospective Observational Study
The Effect of Urinating Through the Zipper or by Pulling Down the Trousers on Uroflowmetry Parameters in LUTS
Does Antibiotic Prophylaxis at Urinary Catheter Removal Prevent Urinary Tract Infections
Comparison of the Effect of Remimazolam and Propofol on Perioperative Hypothermia Under Spinal Anesthesia
Effect of Cranberry Extract on the Urinary System
Does Homebrewing Beer Affect Urinary Tract Symptoms and Bladder Cancer
To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease
Effect of Deep Brain Stimulation on Lower Urinary Tract Function
Brain Effects of Sacral Neuromodulation